We provide you with 20 years of free, institutional-grade data for RXRX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of RXRX. Explore the full financial landscape of RXRX stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-08-05 | 1601830 | RXRX | 10-Q | Url |
| 2025-05-05 | 1601830 | RXRX | 10-Q | Url |
| 2025-02-28 | 1601830 | RXRX | 10-K | Url |
| 2024-11-06 | 1601830 | RXRX | 10-Q | Url |
| 2024-08-08 | 1601830 | RXRX | 10-Q | Url |
| 2024-05-09 | 1601830 | RXRX | 10-Q | Url |
| 2024-02-29 | 1601830 | RXRX | 10-K | Url |
| 2023-11-09 | 1601830 | RXRX | 10-Q | Url |
| 2023-08-08 | 1601830 | RXRX | 10-Q | Url |
| 2023-05-08 | 1601830 | RXRX | 10-Q | Url |
| 2023-02-27 | 1601830 | RXRX | 10-K | Url |
| 2022-11-08 | 1601830 | RXRX | 10-Q | Url |
| 2022-08-09 | 1601830 | RXRX | 10-Q | Url |
| 2022-05-10 | 1601830 | RXRX | 10-Q | Url |
| 2022-03-23 | 1601830 | RXRX | 10-K | Url |
| 2021-11-10 | 1601830 | RXRX | 10-Q | Url |
| 2021-08-13 | 1601830 | RXRX | 10-Q | Url |
| 2021-05-12 | 1601830 | RXRX | 10-Q | Url |
| 2021-03-22 | 1601830 | RXRX | S-1 | Url |
Recursion Pharmaceuticals, Inc.(NASDAQ:RXRX) 
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. It has four clinical-stage drug candidates focused on rar...
Website: http://www.recursion.com
Founded: 2013
CEO: Chris Gibson
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report about RXRX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.